HIV (the virus that causes AIDS) spreads through specific body fluids: blood, semen, pre-seminal fluid, vaginal fluids, rectal fluids, and breast milk. For transmission to occur, one of these fluids from a person with HIV must enter another person’s body through a mucous membrane, damaged tissue, or direct injection into the bloodstream. That requirement is important because it means casual, everyday contact poses no risk.
Sexual Transmission
Sex is the most common route of HIV transmission worldwide, but the risk varies dramatically depending on the type of sexual contact. The CDC estimates risk per act (assuming no condoms, no preventive medication, and no treatment) as follows:
- Receptive anal sex: roughly 1 in 72 acts, the highest-risk sexual activity
- Insertive anal sex: roughly 1 in 909 acts
- Receptive vaginal sex: roughly 1 in 1,250 acts
- Insertive vaginal sex: roughly 1 in 2,500 acts
Receptive anal sex carries the highest per-act risk because the rectal lining is thin, has a rich blood supply, and is more susceptible to small tears during intercourse. Vaginal tissue is thicker and more resilient, which partly explains the lower numbers. Oral sex carries a much lower risk, though it isn’t zero if there are open sores, bleeding gums, or contact with semen or vaginal fluids.
These numbers represent averages. The actual risk in any single encounter depends on factors like the amount of virus in the HIV-positive partner’s blood (viral load), the presence of other sexually transmitted infections, and whether there are cuts or sores on the genitals. An untreated person with a high viral load is far more infectious than someone whose virus is well controlled.
Needle Sharing and Injection Drug Use
Sharing needles, syringes, or other injection equipment is the second major transmission route. When someone injects drugs with a syringe that was used by a person with HIV, a small amount of blood remaining in the needle or syringe can carry the virus directly into the bloodstream. The estimated probability of infection from a single injection with a contaminated syringe is about 0.67%, or roughly 1 in 150. That’s about three times higher than the per-act risk of vaginal sex.
This risk applies to any situation involving shared needles, not just recreational drug use. Tattooing or piercing with unsterilized equipment, though rare in regulated settings, carries the same basic mechanism of blood-to-blood contact.
Mother-to-Child Transmission
HIV can pass from mother to child during pregnancy, labor, delivery, or breastfeeding. Without any treatment, the combined risk is substantial: 15 to 30% during pregnancy and labor, with an additional 10 to 20% risk from prolonged breastfeeding. In parts of Africa where treatment access was historically limited, overall mother-to-child transmission rates reached 25 to 35%.
Treatment has transformed this picture. When a pregnant person with HIV takes antiretroviral therapy and achieves an undetectable viral load (below 50 copies per milliliter of blood), the transmission rate drops to 1 to 2%. This is now the standard of care in most countries with adequate healthcare infrastructure, and it’s one of the clearest success stories in HIV prevention.
Blood Transfusions and Medical Settings
In the early years of the epidemic, contaminated blood products were a significant source of infection. Modern screening has virtually eliminated this risk. In the United States, the residual risk of HIV transmission from a blood transfusion is estimated at 0.35 per million units of packed red blood cells. For practical purposes, the blood supply in countries with rigorous screening protocols is extremely safe.
Healthcare workers face a small occupational risk from needlestick injuries or exposure to infected blood. The baseline risk from a single needlestick with HIV-positive blood is roughly 1 in 200 to 1 in 300, and post-exposure treatment (described below) reduces that risk further.
How HIV Does Not Spread
HIV does not survive well outside the human body. It cannot spread through saliva, sweat, tears, or urine in normal circumstances. This means you cannot get HIV from hugging, shaking hands, sharing food or drinks, using the same toilet, or being near someone who coughs or sneezes. Mosquitoes and other insects do not transmit HIV either.
The virus requires a very specific set of conditions: the right body fluid, in sufficient quantity, reaching the bloodstream or a mucous membrane. Mucous membranes line the inside of the rectum, vagina, penis (at the urethra and foreskin), and mouth. Intact skin is an effective barrier. The rare cases of transmission through casual contact documented in medical literature involved direct exposure of open wounds or broken skin to blood, not the kind of contact people have in daily life.
Undetectable Means Untransmittable
One of the most important developments in HIV science is the confirmation that people on effective treatment who maintain an undetectable viral load do not transmit the virus sexually. The landmark PARTNER study followed couples where one partner had HIV and the other did not. Over thousands of acts of condomless sex, including anal sex, there were zero linked transmissions when the HIV-positive partner’s viral load was below 200 copies per milliliter.
The study’s statistical analysis was striking: even in the highest-risk scenario (receptive anal sex with ejaculation), the upper boundary of risk was equivalent to one possible transmission per 175 couple-years of condomless sex. In practical terms, the risk is effectively zero. This finding, summarized as U=U (Undetectable equals Untransmittable), has been endorsed by health agencies worldwide and has significant implications for reducing stigma and encouraging treatment.
Prevention Tools That Reduce Risk
Beyond treatment for people already living with HIV, several tools can prevent new infections. PrEP (pre-exposure prophylaxis) is a medication taken by HIV-negative people before potential exposure. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. For people who inject drugs, PrEP pills reduce risk by at least 74%.
Condoms remain effective and widely accessible. When used consistently and correctly, they block the exchange of body fluids that carry the virus. Combining condoms with PrEP or the HIV-positive partner’s treatment provides layered protection that makes transmission extraordinarily unlikely.
PEP (post-exposure prophylaxis) is an emergency option for people who may have just been exposed to HIV. To be effective, PEP must be started within 72 hours of exposure, and sooner is better. An early study of PEP in healthcare workers showed an 81% reduction in infection. PEP involves taking antiretroviral medication daily for 28 days, and it is not effective if started more than three days after exposure.